Allergen immunotherapy (AIT) is a safe and effective treatment of allergic diseases, however the occurrence of local or systemic adverse drug reactions can never be ruled out during administration of allergens. Reporting adverse drug reactions after authorization of the medicinal product is of great importance. It allows continuous monitoring of the benefit-risk balance of our products. In order to ensure the safety of our patients and products, our Drug Safety Department collects and assesses reports of adverse drug reactions. Additionally, we are legally obliged to document reports of adverse drug reactions and need to fulfill reporting requirements to Health Authorities.
To report any undesirable side effect electronically please click below for download of the respective form. Thank you for your support